Research was conducted to determine if directing expression of insulin-like growth factor I (IGF1) specifically to striated muscle would enhance lean muscle growth in swine. At 120 kg BW, 25 transgenic (T) and 26 control (C) pigs were sacrificed to evaluate carcass composition. T-pigs had lower percentages of fat and higher percentages of lean tissues than C-pigs for the overall carcass and each carcass region (P ≤ 0.002 for each). Expression of the IGF1 transgene did not alter the percentages of the three fiber types in the five skeletal muscles, however, fiber areas of longissimus dorsi muscle (LM) and serratus ventralis were larger (P ≤ 0.031) in T-than in C-pigs. In Tpigs the relative abundance of IGF1 mRNA in gastrocnemius, gluteus medius, LM, and the average for all five skeletal muscles (ASM) was positively (P ≤ 0.011) correlated with percentage of carcass lean (r = +0.597 to 0.804), whereas the relative abundance of IGF1 mRNA in the LM and the ASM was negatively (P ≤ 0.047) correlated with average backfat (r = -0.546 and -0.488, respectively). Based on these results we conclude that expression of IGF1 specifically in skeletal muscle had a positive effect on carcass composition of swine. Introduction Although growth is primarily regulated by growth hormone (GH), many of its effects are mediated by insulin-like growth factor-I (IGF1), a single-chain mitogenic polypeptide. Recent research with liver-specific IGF1 deficient mice has provided direct evidence that IGF1 acts locally in a paracrine/autocrine fashion to mediate GH rather than by the endocrine mode in stimulating growth of somatic tissues (SJOGREN et al., 1999; YAKAR et al., 1999) . Administration of IGF1 to pigs (WALTON et al., 1995; KLINDT et al., 1998) and lambs (COTTAM et al., 1992; MIN et al., 1996) did not enhance lean body mass. KLINDT et al. (1998) observed an increase in adipose deposition in pigs injected twice daily with recombinant (r)hIGF1 for four weeks even though serum IGF1 was elevated by 60% compared to untreated pigs. Lack of growth enhancement in these studies may be the unintended consequence of elevated plasma IGF1 inducing negative feedback of IGF1 on the hypothalamus, which would depress GH secretion from the pituitary (KLINDT et al., 1998) . To avoid the consequences that might ensue from depressed GH secretion, Coleman et al. (1995) constructed a skeletal α-actin-hIGF1 transgene to direct IGF1 expression specifically in striated muscle of transgenic mice. Their objective was to direct sufficient expression of IGF1 in muscle to act as a paracrine agent without altering plasma IGF1 concentration sufficiently to depress GH synthesis and secretion. The skeletal α-actin-hIGF1 transgene was subsequently transferred into swine to investigate its potential for improving productivity. The production and preliminary characterizations of the founder IGF1 transgenic pigs have been described (PURSEL et al., 1999) . The purpose of the present paper is to further elucidate the impact of IGF1 expression on the carcass characteristics and muscle fiber morphology of the progeny from six transgenic founder swine.
Introduction
Although growth is primarily regulated by growth hormone (GH), many of its effects are mediated by insulin-like growth factor-I (IGF1), a single-chain mitogenic polypeptide. Recent research with liver-specific IGF1 deficient mice has provided direct evidence that IGF1 acts locally in a paracrine/autocrine fashion to mediate GH rather than by the endocrine mode in stimulating growth of somatic tissues (SJOGREN et al., 1999; YAKAR et al., 1999) . Administration of IGF1 to pigs (WALTON et al., 1995; KLINDT et al., 1998) and lambs (COTTAM et al., 1992; MIN et al., 1996) did not enhance lean body mass. KLINDT et al. (1998) observed an increase in adipose deposition in pigs injected twice daily with recombinant (r)hIGF1 for four weeks even though serum IGF1 was elevated by 60% compared to untreated pigs. Lack of growth enhancement in these studies may be the unintended consequence of elevated plasma IGF1 inducing negative feedback of IGF1 on the hypothalamus, which would depress GH secretion from the pituitary (KLINDT et al., 1998) . To avoid the consequences that might ensue from depressed GH secretion, Coleman et al. (1995) constructed a skeletal α-actin-hIGF1 transgene to direct IGF1 expression specifically in striated muscle of transgenic mice. Their objective was to direct sufficient expression of IGF1 in muscle to act as a paracrine agent without altering plasma IGF1 concentration sufficiently to depress GH synthesis and secretion. The skeletal α-actin-hIGF1 transgene was subsequently transferred into swine to investigate its potential for improving productivity. The production and preliminary characterizations of the founder IGF1 transgenic pigs have been described (PURSEL et al., 1999) . The purpose of the present paper is to further elucidate the impact of IGF1 expression on the carcass characteristics and muscle fiber morphology of the progeny from six transgenic founder swine.
Material and Methods

Animals
The 26 control (12 gilts and 14 boars) and 25 transgenic pigs (11 gilts and 14 boars) used in this study were first generation (G1) progeny of 11 litters that resulted from the mating of three IGF1 founder transgenic gilts with three unrelated non-transgenic boars (Orange Line Hybrid, DeKalb Swine Breeders, Inc., DeKalb, Ill.) and three IGF1 transgenic boars with two or three unrelated non-transgenic DK-43 hybrid gilts (DeKalb Swine Breeders, Inc., DeKalb, Ill.). The founder transgenic pigs were produced with a fusion gene composed of avian skeletal α-actin (SK733) regulatory sequences and a cDNA encoding human IGF1 as described by COLEMAN et al. (1995) . Presence of the IGF1 transgene was established by Southern blot hybridization analysis of DNA from tail biopsies. Details regarding the housing, nutrition, management, and experimental conditions pigs were exposed to before slaughter are described in a separate paper (PURSEL et al., 2004) . The mean live weight at slaughter differed for control and transgenic gilts (118.3 vs. 121.8 kg, P < 0.05) but not for the boars (120.7 vs. 120.4 kg, P > 0.05). Control and transgenic gilts were older (P < 0.05) at slaughter (200.8 and 206.7 d) than control and transgenic boars (187.9 and 197.9 d; age of transgenic and controls at slaughter did not differ (P > 0.05). The Beltsville Area Institutional Animal Care and Use Committee approved experimental protocols used in this research.
Carcass evaluation
When pigs weighed about 120 kg they were transported to the Beltsville ARS abattoir (establishment # 68), electrically stunned and exsanguinated, the head and viscera were removed, and the carcass split at the midline. The hair and feet remained on the carcass. The right half of each carcass was chilled for 24 h, weighed, and then scanned by dual energy x-ray absorptiometry (DXA) using a Lunar DPX-L densitometer (Madison, WI). The DXA total body results provided measurements of fat, lean, bone mineral, and total tissue mass. After the DXA scan was performed, each carcass was homogenized by grinding as described previously (MITCHELL et al., 1994) . Homogenized tissue samples were analyzed for the content of fat by chloroformmethanol extraction (FOLCH et al., 1957) (CV = 0.9%), of protein by Kjeldahl nitrogen determination (CV = 2.4%) and of water by lyophilization (CV = 1.9%). To compare DXA bone mineral content to total carcass ash by combustion, the total carcass ash content was corrected for the ash content of 0.85% for boneless pork meat (JEBB et al., 1995) . The DPX-L (adult mode) software allows manual regional analysis, providing fat, lean, bone mineral content (BMC), and total tissue mass for each user defined region. Using this option, the DXA scan results were analyzed by dividing the carcass into four regions: ham, shoulder, loin, and side (belly). The following prediction equations for conversion of DXA fat values were derived from the data published by MITCHELL et al. (1998) , and percentage of DXA bone was based on the 24.14% ash content of pork bones reported by FIELD et al. (1974) . Total carcass length was measured. The loin eye area (LEA) was determined at the level of the 10th rib of the longissimus muscle (LM), fat thickness (P2BF) over the LM was measured at 65 mm from the midline at the 10th rib, and average backfat thickness (ABF) was determined from midline measurements at the first and last ribs and at the last lumbar vertebra.
Tissue Sampling and Histochemical Methods
After the pigs were eviscerated the adrenals, heart, liver, kidneys, ovaries, spleen, and testis were weighed, and 5-g samples of heart and liver were wrapped in aluminum foil, frozen in liquid nitrogen, and stored at -70 ºC until mRNA analyses were performed. Each stomach was emptied, rinsed under tap water and the esophageal region visually evaluated by a modification of the scoring system described by EISMANN and ARGENZIO (1999) . Degree of erosion and ulceration was scored on a scale of 1 to 6, with 1 having smooth surface throughout the pars esophagea, 2 showed some cornification and papillae elongation, 3 having extensive cornification and papillae development, 4 having some tissue erosion, 5 having extensive tissue erosion and small ulceration, and 6 being completely ulcerated.
Five muscles were removed from the left side of each carcass for histochemical and RNA analyses within 15 min after exsanguination. The torso muscles included LM and serratus ventralis (SV); the hind limb muscles included gastrocnemius (GC), gluteus medius (GM), and semitendinosus (ST). The weight, girth, and length of each ST muscle were measured after muscle excision. Muscle samples for fiber determination were taken from the central region of the SV, GC, GM, from the center of the dark portion of the ST, and the anterior part of the 12th rib location of the LM. One piece (approximately 1 cm x 1 cm x 3 cm) of each muscle was immediately fixed on a labeled flat stick, rolled in talcum powder, and frozen in liquid nitrogen, and a 5-g sample from the same vicinity of each muscle was collected, wrapped in aluminum foil, and frozen in liquid nitrogen. Both sets of samples were stored at -70 ºC until muscle morphology and mRNA analyses were performed. For fiber determination, frozen muscles samples were equilibrated to -25 ºC, cut from stick, and trimmed to facilitate transverse sectioning. Samples were mounted on a cryostat chuck with a few drops of tissue freezing medium (Triangle Biomedical Science, Durham, NC). Six-micrometer-thick sections were cut using a Cryostat 2800 Frigocut-E (Reichert-Jung, Cambridge Instruments, Deerfield, IL). Sections were mounted on glass microscopic slides and were allowed to air-dry for 30 min. The sections were treated with the combination succinic dehydrogenase and acid myofibrillar ATPase staining procedure (SOLOMON and DUNN, 1988) . The stained sections were observed at 200X with a Zeiss Confocal microscope in transmitted light mode (Carl Zeiss MicroImaging, Inc., Thornwood, NY). Muscle fibers were classified as slow oxidative (SO), fast oxidative glycolytic (FOG), and fast glycolytic (FG) based on the stain reaction. The SO fibers showed the darkest and FG the lightest staining intensity. Four random fields at different location within a slide of each muscle sample were captured as TIF-files and analyzed with the Kontron 300 image analysis software (Kontron Elektronik Corp., Newport Beach, CA). To minimize the incidence of measuring intrafasicular terminations of myofibers, only fibers larger than 1000 µm 2 were included in calculations. Fiber type distribution was calculated in two ways. One method expresses the percentage of each fiber type to the total of all measured fibers (FNP). The other method expresses the percentage of the total measured area relative to the area of each fiber type (FAP). Numbers of fibers in ST was estimated by extrapolating the number of fibers in a known area under the microscope to the girth of the ST at the midpoint between attachments.
Muscle IGF1 mRNA A 772 base pair PstI fragment of hIGF1 cDNA (JANSEN et al., 1983) was used for detection of IGF1 mRNA. Total RNA was isolated from guanidine isothionate homogenates using phenol-chloroform extraction and ethanol precipitation. For Northern blot hybridization, 20 µg of total RNA was denatured at 55 ºC and fractionated on 1% agarose -0.66M formaldehyde gel under 3.5 volts/cm for 75 min. The RNA on the gel was then transferred onto nylon membranes (Nytran®, Schleicher & Schuell, Keene, NH) by the downward transfer (Turboblotter™, Schleicher & Schuell, Keene, NH) and immobilized by UV cross-linking. Blots were hybridized with a Digoxigenin (DIG)-labeled hIGF1 probe (Boehringer Mannheim, Indianapolis, IN) at 50 ºC overnight. After the membrane was washed twice for 5 min in 2X SSC -0.5% SDS at room temperature and washed twice for 15 min in 0.5X SSC -0.1% SDS at 68 ºC, it was incubated in a blocking solution, followed by an anti-DIG antibodyalkaline phosphate conjugate solution (Boehringer Mannheim, Indianapolis, IN). IGF1 mRNA was visualized by applying a fluorescence substrate, ECF™ (Amersham Phamacia Biotech, Piscataway, NJ) on the membrane and incubating at room temperature for several hours. A Fluoroimager™ (STORM 860, Molecular Dynamics, Sunnyvale, CA) was used to determine signal intensity. The intensity of IGF1 mRNA signal was normalized for β-tubulin for comparison.
Shear Force Tenderness
After the muscle fiber and mRNA tissue samples were removed from the excised LM, the remaining portion ~30 cm in length was vacuum packaged and refrigerated (2 ºC) through 5 d postmortem and then frozen and stored at -20 ºC for subsequent shear force determinations. Two chops (2.5 cm in thickness) from each frozen LM section were removed and thawed for 18 to 20 h at 2 ºC. Chops were cooked (broiled) to an internal temperature of 75 ºC, turning once at 40 ºC, using Farberware Open-Hearth broilers (Model 350A, Farberware Co., Bronx, NY). Internal temperature was monitored using iron-constantan thermocouples attached to a recording potentiometer. Cooking yields were recorded (weight of chop before and after being cooked). Chops were allowed to cool to room temperature (25 ºC) before coring. A minimum of four cores (1.3 cm in diameter) were removed from each chop, parallel to the muscle-fiber orientation, and these cores were used for shear force determination using a WarnerBratzler shear test cell mounted on a Food Texture Corp. (FTC) texture measurement system (Model TMS-90, FTC, Chantilly, VA) using a 3.18 mm thick blade, Vnotched, and crosshead speed of 25 cm/min.
Statistical Analysis
Variables for carcass composition, organ, ST weights, shear force, cooking yield, and erosion score were analyzed as a two factor general linear mixed model using the mixed procedure of SAS. Gene, sex, and interaction were fixed effects, with litter as a random factor. Half carcass weight and live weight were used as covariates for carcass composition measures and organ weights, respectively. Least squares means for gene within sex were separated by the PDIFF option of SAS when gene x sex (G x S) interactions were significant. All statistical analyses were conducted using the SAS System version 6.12 (SAS Inst. Inc., Cary, NC). The fiber area variable was analyzed for each muscle as a three-factor split plot mixed model using the mixed procedure of SAS. Gene and sex were the whole plot fixed effects, muscle fiber type the subplot fixed effect, with litter and litter x gene x sex as random factors. When it was necessary to correct for variance heterogeneity, the data was grouped either by gender or gene and separate variance estimates for each of the groups were used in the analysis. Fiber type distribution variables were analyzed for each fiber type and muscle as a two factor general linear mixed model using the mixed procedure of SAS. Gene and sex were fixed effects, with litter as a random factor. When it was necessary to correct for variance heterogeneity, the data was grouped by sex and separate variance estimates for each group were used in the analysis. Pearson's correlation coefficients were calculated between normalized values for muscle IGF1 mRNA abundance, muscle fiber area, and carcass composition measures of the transgenic pigs, between normalized values for heart IGF1 mRNA abundance and organ weights, and between the mean of IGF1 mRNA abundance for the five skeletal muscles and organ weights. Normalized IGF1 mRNA abundance for heart and the five skeletal muscles were analyzed by the GLM procedure of SAS. Muscle, sex, line, and interactions were fixed effects. Since interactions were not significant (P > 0.10), they were excluded from the model. Least squares means for heart vs. skeletal muscles were compared by orthogonal contrast, and least squares means among skeletal muscles were separated by the PDIFF option of SAS.
Results
DXA Evaluation of Half Carcasses
The effects of the IGF1 transgene on carcass composition as assessed by DXA analysis of the right half of each carcass and the four major primal cut regions are summarized in Table 1 . The percentage of carcass fat was lower (P ≤ 0.002) and the percentage of lean tissue was higher (P ≤ 0.001) in transgenic than control pigs for the overall carcass as well as in each of the separate carcass regions. Carcass fat was 10 and 6.9% lower (P < 0.001) in transgenic gilts and boars, respectively, compared to sibling controls. Transgenic gilts and boars had 7.3 and 3.2% more (P < 0.001) carcass lean, respectively, than sibling controls. The percentage of carcass bone did not (P = 0.110) differ between transgenic and control pigs. In both the shoulder and loin regions boars had less (P = 0.004) bone percentage than gilts. The percentage of the total carcass weight contained in each of the separate regions did not (P > 0.05) differ for transgenic and control pigs.
Direct Carcass Measurements
Carcass dressing percentage, average backfat, P2 backfat depths, and carcass lipid concentration were lower (P ≤ 0.026) and carcass water was higher (P = 0.024) in transgenic pigs than in the controls (Table 2) . Gilts had higher (P < 0.001) dressing percentage, less (P ≤ 0.001) subcutaneous adipose and overall carcass lipids and higher (P < 0.001) percentage carcass water than boars. These differences tended to be larger between transgenic and control gilts than between transgenic and control boars (G x S interaction: P ≤ 0.098). Total carcass length and percentage of total carcass protein did not (P ≥ 0.113) differ between transgenic and control pigs. Loin eye areas were 14.5% larger (P < 0.001) in transgenic gilts and boars than sibling controls. Shear force values and cooking yield for LM did not (P ≥ 0.182) differ between transgenic and control pigs. a Pars esophageal region of stomach was scored on scale of 1 (smooth) to 6 (frank ulceration). bc Within a row and within boars, means without a common superscript letter differ (P < 0.05).
Organ Weights and Stomach Erosion Scores
The hearts and kidneys of the transgenic pigs were heavier (P ≤ 0.030) than those of the control siblings and were heavier (P ≤ 0.008) in boars than gilts (Table 3) . Weights of adrenals, liver, ovaries, spleen, and testis were similar (P ≥ 0.181) for transgenic and control pigs but the adrenal was lighter (P ≤ 0.041) and liver was heavier (P = 0.002) in boars than in gilts. The erosion scores of pars esophageal region of the stomach were higher in transgenic boars than in control boars, but erosion scores did not differ among gilts (G x S interaction, P = 0.036).
Fiber Type Distribution
The transgenic and control pigs did not (P ≥ 0.114) differ in the percentage of each fiber type for the GM, LM, ST, and SV regardless of whether the percentages were based on the FNP (Table 4) or FAP (Table 5 ). In the GC muscle transgenic gilts had a lower FAP of FOG fibers and a higher FAP of FG fibers than the control gilts whereas the reverse occurred in transgenic and control boars (G x S interaction; P ≤ 0.025). Fiber type distribution based on FNP was similar (P ≥ 0.057) for gilts and boars in the GC, ST, LM, and SV muscles. However, in the GM muscle, boars had a higher (P = 0.017) percentage of FOG fibers and lower (P = 0.019) percentage of FG fibers than the gilts. When fiber type distribution was based on FAP gilts and boars had similar (P ≥ 0.053) percentages in GC, GM, and ST muscles. However, in gilts LM had a higher (P = 0.017) percentage of FG fibers and lower (P = 0.017) percentage of FOG fibers than in boars, and in the SV muscle boars had a higher (P = 0.044) percentage of SO fibers than gilts. Among muscles, the percentage of each fiber type varied considerably for both FNP and FAP analyses. 
Muscle Fiber Areas
Fiber areas of all three fiber types of LM and SV muscles were larger (P ≤ 0.031) in transgenic pigs than in control pigs (Table 6 ). The SO, FOG, and FG fibers of the GM muscle also tended (P = 0.100) to be larger in transgenic pigs than in control pigs. The impact of the transgene on FOG and FG fiber area of the GM muscle tended to be greater in gilts than boars (gene x sex x fiber interaction, P = 0.081). The areas differed among the three fiber types with FG fiber area being larger than SO or FOG fibers in the GC, GM, LM, and SV muscles (P < 0.001 for each), whereas SO and FG fiber area in the ST muscle were similar and larger than the FOG fiber. None of the first order interactions were significant (P > 0.100). Physical measurement data for the ST muscle are shown in Table 7 . The weight and estimated total number of fibers did not (P ≥ 0.186) differ for transgenic and control pigs. However, the girth of the ST was larger (P = 0.016) in transgenic pigs than in controls. The ST was longer (P = 0.041) in gilts than in boars and regardless of the sex tended (P = 0.097) to be shorter in transgenic than control pigs. 
Muscle hIGF1 mRNA
Messenger RNA of hIGF1 was detected on Northern blots of total RNA from skeletal muscle of all transgenic pigs included in this study that was not detected in control pigs. Representative Northern blots for muscle hIGF1 mRNA are shown in Fig. 1 . Transgenic progeny from one founder had multiple indistinct bands on the blots that reacted with the IGF1 probe in contrast to progeny from the other five founders in which only a single discrete band was found (Fig. 1c) . Therefore, quantification of IGF1 mRNA abundance was performed on five skeletal muscles and the heart from transgenic progeny from only the five founders with a single discrete band. Relative abundance of hIGF1 mRNA in the heart and five skeletal muscles are shown in Fig.2 . Level of the IGF1 transgene expression differed (P < 0.05) among the progeny of the five founders and among the muscles that were evaluated. The level of IGF1 mRNA was higher (P < 0.05) in LM than GM, ST, and SV. Abundance of IGF1 mRNA did not (P > 0.05) differ among the other muscles, and did not differ (P = 0.114) for heart vs. skeletal muscles. Although some muscles in boars tended to have higher IGF1 mRNA values than in gilts, the relative abundance did not (P = 0.169) differ.
Correlations of IGF1 mRNA abundance in each muscle and the average for all five skeletal muscles (ASM) with various carcass traits of the transgenic pigs are shown in Table 8 . Levels of IGF1 expression in all skeletal muscles were positively (P ≤ 0.011) correlated with percentage of carcass lean (r = 0.597 to 0.804), and IGF1 expression levels in GC, GM, LM and ASM were positively (P ≤ 0.033) correlated with percentage of carcass water (r = 0.519 to 0.684). In contrast, average backfat and P2 backfat thickness were negatively (P ≤ 0.051) correlated with abundance of IGF1 mRNA in GC, GM, LM, and ASM (r = -0.486 to -0.629), and percentages of carcass lipid and DXA fat were negatively (P ≤ 0.047) correlated with IGF1 mRNA level in LM and ASM (r = -0.488 to -0.600). Loin eye area, percentage carcass bone, carcass protein concentration, and mean fiber area of the muscle were not (P ≥ 0.064) correlated with the abundance of IGF1 mRNA in any of the five skeletal muscles. Except for a positive correlation with DXA bone content (r = 0.488; P = 0.047), IGF1 mRNA abundance in the heart was not (P ≥ 0.456) correlated with carcass measurements. * P < 0.05; ** P < 0.01; *** P < 0.001 a Mean IGF1 mRNA abundance normalized for β-tubulin mRNA. b Loin eye area at 10th rib. c Average backfat thickness at midline measured at first and last ribs and at last lumbar vertebra. d Fat thickness over the LM at the 10th rib measured 65 mm from the midline. e Gastrocnemius (GC), gluteus medius (GM), longissimus (LM), semitendinosus (ST), seratus ventralis (SV), and mean of mRNA abundance for the five skeletal muscles (ASM).
Correlations of IGF1 mRNA abundance in heart and ASM with organ weights for the transgenic pigs are shown in Table 9 . Expression of IGF1 mRNA in the heart was positively correlated with the heart weight (r = 0.612, P = 0.009). Weights of the adrenal, the liver, the ovary, and the testis were not (P ≥ 0.134) correlated with IGF1 mRNA levels, and spleen and kidney weight was approaching a positive (P > 0.078) correlation with IGF1 mRNA abundance in the heart (r = 0.492 and 0.439, respectively). Discussion Expression of an IGF1 transgene, which was directed specifically to skeletal muscle by skeletal α-actin regulatory sequences, induced a shift from deposition of fat in the carcass to enhanced accretion of lean tissues. In the transgenic pigs the percentage of lean tissue in each of the four primary regions of the carcass and the loin eye area were all significantly elevated in contrast to significant reductions in average backfat and P2 backfat depth and percentages of carcass fat estimated by DXA in comparison to sibling controls. The magnitude of this shift in carcass composition was uniformly larger in gilts than in boars. This difference in response due to gender is in accordance with previous observations of differing gender responses to exogenous porcine growth hormone (pGH) administration to swine KRICK et al., 1992; KLINDT et al., 1995a) . These findings parallel our preliminary results with the IGF1 transgenic founder pigs (PURSEL et al., 1999) that generated the subjects used in the present study. The enhancement of carcass lean at the expense of carcass fat in the IGF1 transgenic pigs contrasts sharply from results obtained with exogenous IGF1 administration to pigs (WALTON et al., 1995; KLINDT et al., 1998) and lambs (COTTAM et al., 1992; MIN et al., 1996) . KLINDT and coworkers (1998) observed an increase in leaf fat, empty body fat, and carcass and empty body energy content in pigs injected twice daily with recombinant (r)hIGF1 for four weeks. It seems unlikely that the dosage of rhIGF1 administered was insufficient to achieve a physiological response, because serum concentrations were elevated by 60% compared to untreated control pigs throughout the experiment. We believe the divergence of our findings with those obtained with exogenously administered IGF1 is the direct result of the IGF1 transgene being expressed in the skeletal muscle where the active peptide induced a paracrine response. In the IGF1 transgenic pigs, circulating concentrations of IGF1 were only elevated by 19% in gilts and 11% in boars and plasma pGH concentrations were unaltered in comparison to sibling controls (PURSEL et al., 2004) . In contrast, twice daily injections of IGF1 resulted in a 60% increase in serum IGF1, where it could potentially have an endocrine effect on skeletal muscle, but also depressed serum concentrations of pGH due to negative feedback on the hypothalamus/pituitary axis (KLINDT et al., 1998) . It seems likely that the increase in leaf fat and empty body fat KLINDT et al. (1998) observed was a response to the depressed pGH rather than a direct lipogenic affect of IGF1, as suggested by the investigators. The magnitude of alterations in carcass composition elicited by expression of the IGF1 transgene was somewhat lower than it has been reported for pigs administered exogenous growth hormone (see reviews by STEELE et al., 1994; ETHERTON and BAUMAN, 1998) . However, direct comparisons of our results with those published for pGH-treated pigs are difficult, because results from those studies varied greatly depending on gender KRICK et al., 1992; KLINDT et al., 1995a) , duration of treatment (SMITH and KASSEN, 1990; KLINDT et al., 1995b) , treatment dose (EVOCK et al., 1988; BEERMANN et al., 1990; THIEL et al., 1993) , genetic background KRICK et al., 1992; KLINDT et al., 1995a) , slaughter weight (KANIS et al., 1990) , and whether the pGH was administered by daily injection or by implant (BUONOMO et al., 1991) . In addition, results in the present study varied considerably depending on the transgenic founder as well as the non-transgenic sire or dam of the progeny. Consequently, too few transgenic and control progeny of each sex were produced per founder to permit meaningful comparisons among founder lines. Organomegaly is a common characteristic of pigs administered pGH. Depending on genetic background and gender, weight increases in heart by 2 to 33.5%, in liver by 14.5 to 50%, in kidney by 14 to 65%, and in spleen by 1.3 to 35.7% were reported for GH treated pigs (KLINDT et al., 1995a) . Similar increases in organ weights have also been reported for transgenic pigs (PURSEL et al., 1989 , 1997 ), sheep (NANCARROW et al., 1991 , and mice (HAMMER et al., 1985; POMP et al., 1992) expressing GH transgenes. In contrast, in the IGF1 transgenic pigs, the weight of the hearts was increased by only 6.5% in gilts and 9.1% in boars, weight of kidneys was increased by 18.3% in gilts and 4.6% in boars, and adrenals, liver, ovaries spleen, and testis did not differ from that of sibling controls. These findings are similar to the 7% increase in heart weight and the 19.6 % increase in kidney weight in barrows that had been administered rhIGF1 twice daily for four weeks (KLINDT et al., 1998) . In addition, COTTAM and coworkers (1992) reported that administration of rhIGF1 to weathers three times daily for 8 weeks resulted in a 10.5% increase in kidney weight, no increase in heart or liver weight, and a 45% increase in spleen weight. Splenomegaly has also been reported in hypophysectomized and GH-deficient dwarf rats treated with IGF1 (GULER et al., 1988; SKOTTNER et al., 1989) and IGF1 transgenic mice (MATHEWS et al., 1988) . The general lack of organomegaly in the IGF1 transgenic pigs as well as in IGF1-treated pigs and lambs is consistent with the inability of IGF1 to stimulate growth rate and improve efficiency of feed utilization. An increase in incidence of gastric ulcers has been reported in GH-treated growing pigs (MCLAREN et al., 1990; KASSON, 1990, 1991) , in lactating sows (CROMWELL et al., 1989) , and in transgenic pigs that were expressing high levels of bovine and ovine GH (PURSEL et al., 1989 (PURSEL et al., , 1997 . The increase in stomach erosion score observed in the transgenic boars compared to the control boars was primarily the result of a high incidence in gastric ulcers in the 16 progeny of one founder (scores of 5 or 6 were found in 2 out of 5 control and 2 out of 4 transgenic gilts and 0 out of 2 control and 3 out of 5 transgenic boars). The low number of control boar progeny was the primary factor leading to the significant gene by sex interaction we obtained in this study. The erosion and ulceration that occurred in all pigs was most likely exacerbated by the fineness of the grind and pelleting of the feed (EISEMANN and ARGENZIO, 1999) . In addition, the stress of being anesthetized and scanned by DXA at body weights of 60 and 90 kg and the day before slaughter may have contributed to the stomach erosion and ulceration. With the histochemical staining procedure used in this study three muscle fiber types (SO, FOG, and FG) can be differentiated. However, results of recent studies revealed the existence of 4 muscle fiber types in the LM of pigs at 100 kg of BW, each one expressing a distinct myosin heavy chain isoform (I, IIa, IIx, and IIb; LEFAUCHEUR et al., 2002; LEFAUCHEUR, 2006; TONIOLO et al., 2004) . LEFAUCHEUR et al. (2002) reported that compared with IIb, IIx muscle fibers display also a moderate succinic dehydrogenase staining. Thus, the FOG fibers reported in this study actually contain two distinct populations of myofibers (IIa and IIx). Therefore, the current results do not allow to estimate to what extent IGF1 expression determined the size and the distribution of the IIa and IIx fibers and how the higher expression level in the muscle affected muscle fiber conversion, which follows the obligatory pathway of myosin heavy chain transition (I ↔IIa ↔ IIx ↔ IIb; SCHIAFFINO and REGGIANI, 1994; TONIOLO et al., 2004) . Expression of the IGF1 transgene in the five skeletal muscles examined resulted in a significant increase in fiber area (across all three fiber types) in LM and SV muscles, approached significance in GM, and a trend for an increase in GC and ST muscles as compared to sibling control pigs. The overall percentage of fiber area increase among the muscles of transgenic pigs was inversely related to the average fiber area in control pigs, i.e., rank for average fiber area was SV < LM < GM < GC < ST and increases in fiber area were 14.1, 11.6, 11.1, 3.8, and 2.0%, respectively. In comparison to control pigs, the overall increase in fiber areas for transgenic gilts and boars were 16.2% and 7.6% for LM and 0.5% and 4.4% for ST, respectively, which closely paralleled the 19.9% and 9.6% increase in loin eye areas and 2.3% and 5.0% increase in ST weight. In pigs administered GH, an increase in fiber area that paralleled increased muscle weight and loineye area (LEA) was reported for ST (BEERMANN et al., 1990) and LM . Also, BIEREDER et al. (1999) reported that a group of pigs with high mean diameter of muscle fibers in the M. triceps brachii had a significantly higher IGF1 concentration in the plasma than did a group of pigs in the same study with low muscle fiber diameter in the same muscle. In the present study expression of the IGF1 transgene in the five skeletal muscles did not alter the relative percentages of the three fiber types that were distinguished by staining reaction. We did not see a shift in myofiber type toward more oxidative fiber types that COLEMAN et al. (1995) observed in the gluteus muscles of IGF1 transgenic mice. Most investigators have not observed shifts in the distribution of fiber types in pigs administered GH (SOLOMON et al., , 1990 BEERMANN et al., 1990; ONO et al., 1995) . A shift in distribution from FG to SO was reported for LM (SOLOMON et al., 1991) and for ST when exogenous pGH was administered or evaluated in younger pigs (50 -60 kg BW). Although shear force tenderness did not differ between transgenic and control pigs, the shear values were considerably higher than one typically observes for pork LM muscles . These higher shear values may be a result of prerigor shortening phenomenon since LM muscles were excised from the respective carcasses within 15 min post-exsanguinations and thus removed from any restraints while being stored for 5 d at 2° C. Both the transgenic and control LM samples had shear values averaging 73.6 N and all LM muscles were handled the same way due to the protocol of the study. Previous studies involving transgenic pigs with GH transgenes (SOLOMON et al., 2000) exhibited shear values averaging 34.3 N, however, those LM samples were not removed from the carcasses until after 48 h postmortem. Perhaps the high shear values for the pigs in this study would be mitigated if the muscle samples were left on the carcass for at least the period of time postmortem for the muscle to go into rigor while still attached to the bone and thus more closely resemble meat industry procedures. The relative abundance of IGF1 mRNA in the skeletal muscles for the progeny of the five founders generally agreed with the relative abundance observed in the parental founders (PURSEL et al., 1999) . In addition, no IGF1 mRNA was detected in skeletal muscle of the three founder transgenic boars or their progeny, and the carcass composition of these pigs did not differ from their non-transgenic siblings; data from those non-expressing animals were not included in this paper. Endogenous IGF1 mRNA was not detected in skeletal muscle of non-transgenic pigs even though the IGF1 probe we used was not specific for the IGF1 transgene. Several factors may have been responsible for our failure to detect endogenous IGF1 mRNA in skeletal muscle of non-transgenic pigs and may have diminished the abundance in transgenic pigs. Certainly the time required to dissect and process the multiple muscle samples from each pig was greater in our study than in others in which a single muscle sample was processed (LEAMAN et al., 1990; COLEMAN et al., 1994; PENG et al., 1996) . In addition, our pigs were fasted for 42 h before slaughter compared to a 16 h fast period reported by PENG et al. (1996) . LEAMAN et al. (1990) found that fasting significantly reduced abundance of IGF1 mRNA in heart and skeletal muscle of young pigs, and plasma concentrations of IGF1 are known to decline progressively with duration of fasting in humans (SAVENDAHL and UNDERWOOD, 1999) . Furthermore, abundance of IGF1 mRNA has also been reported to decline with age of pigs from birth to 6 months (PENG et al., 1996) . The significant positive correlations of transgene mRNA abundance in skeletal muscle with carcass lean and heart mRNA level with heart weight combined with significant negative correlations of transgene mRNA levels with several measures of fat deposition provides strong evidence that IGF1 expression was functioning in a paracrine manner as we had originally intended. These collective data also supports growing recognition that the paracrine actions of IGF1 have a greater impact on growth stimulation than circulating concentrations of IGF1. These findings show conclusively that IGF1 can have a major affect on muscle development and carcass composition in swine when delivery is via a muscle-specific transgene. Whether the effects we observed were totally the result of paracrine action or both paracrine and endocrine is an open question because plasma IGF1 was 19 and 11% higher in transgenic gilts and boars, respectively, than in non-transgenic siblings (PURSEL et al., 2004) . However, the experiments in which hepatic IGF1 expression was eliminated in mice through knock-out technology provided direct evidence that IGF1 acts locally in a paracrine/autocrine fashion to mediate GH-induced somatic growth, rather than by IGF1 produced by the liver acting in an endocrine fashion to stimulate growth of somatic tissues (SJOGREN et al., 1999; YAKAR et al., 1999) .
